Hayes William B
Insider CIK 1320940 · BLDR Director · NTEC Director · PTHN Director · INDP Director · LH Chief Financial Officer, EVP
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLDR Builders FirstSource, Inc. | A Award | 2026-09-10 | 2026-09-14 | 583 | — | $0 | 20,221 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2026-09-10 | 2026-09-14 | 583 | — | $0 | 20,221 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2026-06-01 | 2026-06-02 | 508 | $76.26 | $38.7K | 19,638 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2026-05-14 | 2026-05-18 | 2,558 | — | $0 | 19,130 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2026-03-01 | 2026-03-03 | 371 | $104.29 | $38.7K | 16,572 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2025-12-01 | 2025-12-03 | 345 | $112.23 | $38.7K | 16,201 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2025-09-01 | 2025-09-03 | 279 | $138.68 | $38.7K | 15,856 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2025-06-10 | 2025-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2025-06-01 | 2025-06-03 | 359 | $107.68 | $38.7K | 15,577 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2025-05-27 | 2025-05-29 | 1,707 | — | $0 | 15,218 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 250 | $0.50 | $125 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 250 | $0.50 | $125 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 500 | $0.50 | $250 | 0 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2025-03-01 | 2025-03-18 | 269 | $138.99 | $37.4K | 13,511 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2025-02-28 | 2025-03-04 | 269 | $138.99 | $37.4K | 13,511 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2024-12-01 | 2024-12-03 | 201 | $186.47 | $37.5K | 13,242 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2024-09-01 | 2024-09-04 | 215 | $174.00 | $37.4K | 13,041 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2024-06-06 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2024-06-04 | 2024-06-04 | 1,194 | — | $0 | 12,826 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2024-06-01 | 2024-06-04 | 233 | $160.79 | $37.5K | 11,632 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2024-03-01 | 2024-03-05 | 187 | $199.98 | $37.4K | 11,399 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2023-12-01 | 2023-12-05 | 269 | $139.28 | $37.5K | 11,212 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2023-09-01 | 2023-09-06 | 252 | $148.74 | $37.5K | 10,943 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2023-06-14 | 2023-06-16 | 1,446 | — | $0 | 10,691 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2023-06-01 | 2023-06-05 | 323 | $115.86 | $37.4K | 9,245 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2023-05-25 | 2023-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2023-03-01 | 2023-03-03 | 378 | $85.76 | $32.4K | 8,922 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2022-12-01 | 2022-12-05 | 509 | $63.73 | $32.4K | 8,544 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2022-09-30 | 2022-10-03 | 13,750 | — | $0 | 13,750 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2022-09-01 | 2022-09-06 | 553 | — | $0 | 8,035 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2022-06-14 | 2022-06-16 | 2,722 | — | $0 | 7,512 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2022-06-01 | 2022-06-03 | 509 | $63.81 | $32.5K | 4,790 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2022-03-01 | 2022-03-03 | 444 | $73.05 | $32.4K | 4,281 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2021-12-01 | 2021-12-03 | 462 | $70.22 | $32.4K | 18,515 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2021-09-01 | 2021-09-03 | 606 | $53.59 | $32.5K | 18,053 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2021-08-04 | 2021-08-06 | 13,750 | — | $0 | 13,750 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2021-06-15 | 2021-06-17 | 3,459 | — | $0 | 17,447 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2021-06-01 | 2021-06-03 | 730 | $44.47 | $32.5K | 13,988 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2021-03-01 | 2021-03-02 | 766 | $44.84 | $34.3K | 13,258 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2020-12-01 | 2020-12-02 | 800 | $35.93 | $28.7K | 12,492 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2020-09-01 | 2020-09-03 | 928 | $30.98 | $28.7K | 11,692 | SEC↗ |
| NTEC Intec Pharma Ltd. | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2020-06-17 | 2020-06-18 | 5,840 | — | $0 | 10,763 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2020-06-01 | 2020-06-02 | 1,090 | $21.50 | $23.4K | 4,923 | SEC↗ |
| BLDR Builders FirstSource, Inc. | A Award | 2019-10-14 | 2019-10-16 | 3,833 | — | $0 | 3,833 | SEC↗ |
| NTEC Intec Pharma Ltd. | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PTHN Patheon N.V. | U Tender | 2017-08-29 | 2017-08-30 | 17,447 | $35.00 | $610.6K | 0 | SEC↗ |
| PTHN Patheon N.V. | A Award | 2017-03-23 | 2017-03-27 | 6,229 | — | $0 | 17,447 | SEC↗ |
| PTHN Patheon N.V. | M Exercise | 2016-11-01 | 2016-11-02 | 11,905 | — | $0 | 11,905 | SEC↗ |
| PTHN Patheon N.V. | F Tax w/h | 2016-11-01 | 2016-11-02 | 687 | $25.61 | $17.6K | 11,218 | SEC↗ |
| PTHN Patheon N.V. | A Award | 2016-07-20 | 2016-07-22 | 11,905 | — | $0 | 11,905 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2014-06-06 | 2014-06-10 | 28,200 | — | $0 | 28,200 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2014-06-06 | 2014-06-10 | 19,167 | — | $0 | 19,167 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2014-06-06 | 2014-06-10 | 22,100 | $104.50 | $2.31M | 19,400 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2014-06-06 | 2014-06-10 | 28,200 | $90.74 | $2.56M | 47,600 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2014-06-06 | 2014-06-10 | 19,167 | $84.86 | $1.63M | 66,767 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2014-06-06 | 2014-06-10 | 25,267 | $103.99 | $2.63M | 41,500 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2014-04-30 | 2014-05-02 | 2,497 | $98.39 | $245.7K | 19,400 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2014-03-27 | 2014-03-31 | 2,283 | $97.87 | $223.4K | 21,897 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award | 2014-03-27 | 2014-03-31 | 4,780 | — | $0 | 24,180 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2014-03-07 | 2014-03-10 | 19,166 | — | $0 | 38,334 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2014-03-07 | 2014-03-10 | 19,166 | $84.86 | $1.63M | 38,566 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2014-03-07 | 2014-03-10 | 19,166 | $94.50 | $1.81M | 19,400 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2014-03-06 | 2014-03-10 | 280 | $93.99 | $26.3K | 23,802 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2014-03-06 | 2014-03-10 | 2,202 | $94.00 | $207.0K | 21,600 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2014-03-06 | 2014-03-10 | 2,200 | $94.01 | $206.8K | 19,400 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2014-02-28 | 2014-03-04 | 774 | $93.54 | $72.4K | 24,082 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2014-02-12 | 2014-02-13 | 2,816 | — | $0 | 8,474 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2014-02-12 | 2014-02-13 | 934 | $90.98 | $85.0K | 24,856 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2014-02-12 | 2014-02-13 | 2,816 | — | $0 | 25,790 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2014-02-11 | 2014-02-13 | 2,840 | — | $0 | 11,290 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2014-02-10 | 2014-02-12 | 600 | $91.35 | $54.8K | 22,974 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2013-05-21 | 2013-05-23 | 72,200 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2013-05-21 | 2013-05-23 | 55,000 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2013-05-21 | 2013-05-23 | 55,000 | $80.37 | $4.42M | 78,574 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2013-05-21 | 2013-05-23 | 72,200 | $75.63 | $5.46M | 95,774 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2013-05-21 | 2013-05-23 | 55,000 | $100.00 | $5.50M | 23,574 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2013-05-21 | 2013-05-23 | 72,200 | $100.00 | $7.22M | 23,574 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2013-04-11 | 2013-04-15 | 22,234 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2013-04-11 | 2013-04-15 | 22,234 | $70.15 | $1.56M | 45,808 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2013-04-11 | 2013-04-15 | 22,234 | $95.00 | $2.11M | 23,574 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2013-04-01 | 2013-04-03 | 4,949 | $89.96 | $445.2K | 23,574 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2013-03-28 | 2013-04-01 | 5,580 | $90.20 | $503.3K | 28,523 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award | 2013-03-28 | 2013-04-01 | 12,129 | — | $0 | 34,103 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2013-02-28 | 2013-03-04 | 779 | $88.60 | $69.0K | 21,974 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2013-02-12 | 2013-02-14 | 8,450 | — | $0 | 8,450 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2013-02-11 | 2013-02-13 | 735 | $90.06 | $66.2K | 23,343 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2013-02-11 | 2013-02-13 | 590 | $90.06 | $53.1K | 22,753 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2012-05-24 | 2012-05-29 | 57,500 | — | $0 | 57,500 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2012-03-27 | 2012-03-28 | 13,741 | $91.67 | $1.26M | 24,078 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2012-03-26 | 2012-03-28 | 2,750 | — | $0 | 22,234 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2012-03-26 | 2012-03-28 | 10,137 | $91.90 | $931.6K | 37,819 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award | 2012-03-26 | 2012-03-28 | 23,878 | — | $0 | 47,956 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2012-03-26 | 2012-03-28 | 2,750 | $70.15 | $192.9K | 26,828 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2012-03-26 | 2012-03-28 | 2,750 | $90.00 | $247.5K | 24,078 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2012-03-23 | 2012-03-27 | 30,367 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2012-03-23 | 2012-03-27 | 41,716 | — | $0 | 24,984 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2012-03-23 | 2012-03-27 | 59,863 | $89.96 | $5.39M | 24,078 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | S Sale | 2012-03-23 | 2012-03-27 | 16,707 | $88.67 | $1.48M | 83,941 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2012-03-23 | 2012-03-27 | 41,716 | $70.15 | $2.93M | 100,648 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2012-03-23 | 2012-03-27 | 30,367 | $60.04 | $1.82M | 58,932 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award | 2012-02-28 | 2012-03-01 | 7,000 | — | $0 | 28,565 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2012-02-10 | 2012-02-13 | 888 | $90.03 | $79.9K | 21,565 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2012-02-09 | 2012-02-13 | 574 | $92.11 | $52.9K | 22,453 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | F Tax w/h | 2012-02-09 | 2012-02-13 | 718 | $92.11 | $66.1K | 23,027 | SEC↗ |